LIPID BIOSYNTHESIS IN CULTURED ARTERIAL SMOOTH-MUSCLE CELLS IS RELATED TO THEIR PHENOTYPE

被引:15
作者
DUSSERRE, E [1 ]
BOURDILLON, MC [1 ]
CIAVATTI, M [1 ]
COVACHO, C [1 ]
RENAUD, S [1 ]
机构
[1] NATL INST HLTH & MED RES,INSERM,U63,NUTR & VASC PATHOPHYSIOL UNIT,22 AVE DOYEN LEPINE,CP 18,F-69675 BRON,FRANCE
关键词
D O I
10.1007/BF02536051
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
During the atherogenic process in vivo, arterial smooth muscle cells (SMC) undergo changes in their phenotype. In the present study, rat SMC from primary cultures and from subcultures before 10 and after 200 passages, showing contractile-like, synthetic and transformed phenotypes, respectively, were compared in regard to their lipid content and biosynthesis. The rationale for comparing these phenotypes rests in the similar changes in phenotype of SMC that occur in the formation and progression of atherosclerotic lesions. Phenotype changes were shown to be associated with changes in the phospholipid content of SMC. Phospholipid levels increased, but not as significantly as did cholesterol levels when passing from contractile to synthetic and transformed cells (1.23 +/- 0.18, 2.28 +/- 0.26 and 3.25 +/- 0.23 mug/10(6) cells, respectively). Cholesterol normalized in respect to cell protein was increased to the same extent. Lipid synthesis as judged by [C-14]acetate incorporation was increased 3- to 12-fold in the synthetic and transformed cells, respectively, compared to contractile cells. After thin-layer chromatography, radioactivity was shown to be markedly increased in most of the lipid fractions, but label in the cholesterol fraction of synthetic and transformed cells was increased by 7- and 21-fold, respectively. Thus, SMC in vitro were shown to drastically increase cholesterol biosynthesis associated with phenotype changes. Such changes are known to occur in vivo and might represent a critical step in the deposition of excess cholesterol within foam cells.
引用
收藏
页码:589 / 592
页数:4
相关论文
共 33 条
[1]  
ABSHER M, 1989, IN VITRO CELL DEV B, V25, P183
[2]  
Benditt E P, 1980, Int Rev Exp Pathol, V21, P55
[3]  
BLAES N, 1991, IN VITRO CELL DEV B, V27, P725
[4]  
Bourdillon M C, 1977, Prog Biochem Pharmacol, V13, P103
[5]  
BOURDILLON MC, 1989, CLIN TER CARDIOVASC, V8, P293
[6]  
CAMPBELL GR, 1987, VASCULAR SMOOTH MUSC, V1, P39
[7]   CYTODIFFERENTIATION AND EXPRESSION OF ALPHA-SMOOTH MUSCLE ACTIN MESSENGER-RNA AND PROTEIN DURING PRIMARY CULTURE OF AORTIC SMOOTH-MUSCLE CELLS - CORRELATION WITH CELL-DENSITY AND PROLIFERATIVE STATE [J].
CAMPBELL, JH ;
KOCHER, O ;
SKALLI, O ;
GABBIANI, G ;
CAMPBELL, GR .
ARTERIOSCLEROSIS, 1989, 9 (05) :633-643
[8]   METABOLISM OF ATHEROGENIC LIPOPROTEINS BY SMOOTH-MUSCLE CELLS OF DIFFERENT PHENOTYPE IN CULTURE [J].
CAMPBELL, JH ;
REARDON, MF ;
CAMPBELL, GR ;
NESTEL, PJ .
ARTERIOSCLEROSIS, 1985, 5 (04) :318-328
[9]  
FOLCH J, 1987, J BIOL CHEM, V226, P497
[10]  
GABBIANI G, 1988, C INSERM, P179